The human dopaminergic system is a significant focal point of study in the fields of neuropsychiatry and pharmacology, plus it is also a promising nuclear DNA marker in studies of human genome diversity. In this study, we assayed six polymorphic markers in the dopamine D2 receptor gene (DRD2) in 482 unrelated individuals from nine ethnic populations of India. Our results demonstrate that the six markers are highly polymorphic in all populations and the constructed haplotypes show a high level of heterozygosity. Out of the eight possible three-site haplotypes, all populations commonly shared only three haplotypes. The haplotypes exhibited fairly high frequencies across multiple populations; Kurumba population showed all eight three-site hapl...
Aim: Variations of dopamine receptor type 2 (DRD2) are among the key factors involved in the patholo...
Objective: Understanding the etiology and pathogenesis of schizophrenia has been difficult due to th...
Background: Being the primary target of antipsychotic therapy, dopamine receptor type 2 (DRD2) remai...
DNA analysis has made it easier to study haplotypes, arrays of alleles at closely linked loci along ...
Background: Dopamine receptor D2 (DRD2) is an important gene having functional significance in the f...
In recent years, a possible role of the dopamine D2 receptor (DRD2) locus has been reported in vario...
Background: A 48bp variable number of tandem repeat (VNTR), in the dopamine receptor D4 ( DRD4 ), ha...
A better understanding of human genetic variation is important in assessing disease epidemiology and...
Associations of the seven-repeat (7R) allele of the human dopamine receptor D4 (DRD4) gene with both...
Dopamine is a major neurotransmitter in the human brain and is associated with various diseases. Sch...
The dopamine system has long been suspected of aetiological involvement in schizophrenia because of ...
The dopamine transporter (DAT1) is a membrane spanning protein that binds the neurotransmitter dopam...
Abstract Background The human dopamine D4 receptor (DRD4) is a candidate gene of great interest in m...
The dopamine D2 receptor (DRD2) gene locus diplays polymorphic genetic markers. Two of them, the Taq...
Alleles of the dopamine D2 receptor gene are distinguished by polymorphic A and B TaqI sites approxi...
Aim: Variations of dopamine receptor type 2 (DRD2) are among the key factors involved in the patholo...
Objective: Understanding the etiology and pathogenesis of schizophrenia has been difficult due to th...
Background: Being the primary target of antipsychotic therapy, dopamine receptor type 2 (DRD2) remai...
DNA analysis has made it easier to study haplotypes, arrays of alleles at closely linked loci along ...
Background: Dopamine receptor D2 (DRD2) is an important gene having functional significance in the f...
In recent years, a possible role of the dopamine D2 receptor (DRD2) locus has been reported in vario...
Background: A 48bp variable number of tandem repeat (VNTR), in the dopamine receptor D4 ( DRD4 ), ha...
A better understanding of human genetic variation is important in assessing disease epidemiology and...
Associations of the seven-repeat (7R) allele of the human dopamine receptor D4 (DRD4) gene with both...
Dopamine is a major neurotransmitter in the human brain and is associated with various diseases. Sch...
The dopamine system has long been suspected of aetiological involvement in schizophrenia because of ...
The dopamine transporter (DAT1) is a membrane spanning protein that binds the neurotransmitter dopam...
Abstract Background The human dopamine D4 receptor (DRD4) is a candidate gene of great interest in m...
The dopamine D2 receptor (DRD2) gene locus diplays polymorphic genetic markers. Two of them, the Taq...
Alleles of the dopamine D2 receptor gene are distinguished by polymorphic A and B TaqI sites approxi...
Aim: Variations of dopamine receptor type 2 (DRD2) are among the key factors involved in the patholo...
Objective: Understanding the etiology and pathogenesis of schizophrenia has been difficult due to th...
Background: Being the primary target of antipsychotic therapy, dopamine receptor type 2 (DRD2) remai...